Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
signs and symptoms pathological conditions | D013568 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ehlers-danlos syndrome | D004535 | Orphanet_98249 | Q79.6 | — | — | 1 | — | — | 1 |
Syndrome | D013577 | — | — | — | — | 1 | — | — | 1 |
Type iv ehlers-danlos syndrome | D000094623 | — | — | — | — | 1 | — | — | 1 |
Drug common name | Celiprolol |
INN | celiprolol |
Description | 3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea is an aromatic ketone. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 |
PDB | — |
CAS-ID | 56980-93-9 |
RxCUI | — |
ChEMBL ID | CHEMBL27810 |
ChEBI ID | — |
PubChem CID | 2663 |
DrugBank | DB04846 |
UNII ID | DRB57K47QC (ChemIDplus, GSRS) |